Jan 30, 2026
Dr. Tesha Monteith and Dr. Michael Eller discuss the implications of CGRP therapies in migraine treatment, particularly for patients with vascular risk factors or a history of stroke.
Show citation:
Eller MT, Schwarzová K, Gufler L, et al. CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or...
Jan 29, 2026
In part one of this two-part series, Dr. Stacey Clardy and Dr. John Ney break down the key message neurologists need to understand from this update and offer guidance on how to clearly convey it to patients.
Show citation:
Ney JP, Steinmetz JD, Anderson-Benge E, et al. US Burden of Disorders Affecting the Nervous...
Jan 28, 2026
In part two of this four-part series, Casey Kozak discusses Hover's sign, the most well-known test for FND.
Show transcript:
Casey Kozak:
Welcome back to Neurology Minute. My name is Casey Kozak with Rutgers, and today we're continuing our examination of functional neurological disorder. That is physical examination....
Jan 27, 2026
In part one of this four-part series, Casey Kozak breaks down tremors observed during the physical examination of FND.
Show transcript:
Casey Kozak:
Welcome back to Neurology Minute. This is Casey Kozak with Rutgers, and today we'll be discussing a very important and evolving topic, that is Functional Neurological...
Jan 26, 2026
Dr. Margarita Fedorova discusses possible environmental exposures and their risk of Parkinson disease.
Show citation:
Dorsey ER, De Miranda BR, Hussain S, et al. Environmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunities. Lancet Neurol. 2025;24(11):976-986. doi: